Regeneron (REGN) gets its 'mojo back' after FDA approves Eylea HD

August 21, 2023 8:02 AM EDT Send to a Friend
Shares of Regeneron (NASDAQ: REGN) gained over 1% in pre-open trading Monday after the FDA on Friday approved EYLEA HD ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login